Variables | Number (%) | Median (range) | HR (95% CI) | p Value |
---|---|---|---|---|
Grade (1+2/3+4) | 82/21 (80/20) | NA | 0.4 (0.1 to 0.7) | 0.0055** |
TNM stage (I+II/III+IV) | 64/45 (59/41) | NA | 0.4 (0.2 to 0.7) | 0.0020** |
Tumour size, cm (<median/≥median) | NA | 5 (0.7–27) | 0.6 (0.3 to 1.0) | 0.0702ns |
AFP (ng/mL) (<median/≥median) | NA | 52 (1–>70 700) | 0.8 (0.5 to 1.4) | 0.4092ns |
Age (<median/≥median) | NA | 58 (20–84) | 0.5 (0.3 to 0.8) | 0.0106* |
Viral status (non-infected/HepB+C) | 37/72 (34/66) | NA | 1.1 (0.6 to 2.0) | 0.8163ns |
Race (others/Chinese) | 26/83 (24/76) | NA | 1.3 (0.6 to 2.6) | 0.4985ns |
Gender (female/male) | 21/89 (19/81) | NA | 0.7 (0.3 to 1.4) | 0.2903ns |
CD20+ B cell density (<median/≥median) | NA | 16 (0.3–199) | 3.1 (1.9 to 6.0) | <0.0001**** |
CD3+ T cell density (<median/≥median) | NA | 95 (5–840) | 2.9 (1.7 to 5.5) | <0.0001**** |
*p<0.05 **p<0.01 ***p<0.001 ****p<0.0001. AFP, alpha-fetoprotein; TNM, tumour, node, metastases.